TITLE
Letrozole effect on breast cancer tumors

SUMMARY
Analysis of breast cancer tumors following treatment with letrozole for 14 days. The aromatase inhibitor letrozole is an anti-estrogen drug used to treat postmenopausal women with breast cancer. Results provide insight into the molecular mechanism of action of letrozole in breast cancer.

ORGANISM
Homo sapiens

PLATFORM
GPL96 : [HG-U133A] Affymetrix Human Genome U133A Array

CITATIONS
Miller WR, Larionov AA, Renshaw L, Anderson TJ et al. Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. Pharmacogenet Genomics 2007 Oct;17(10):813-26. PMID:  17885619 Miller WR, Larionov A. Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole. Breast Cancer Res 2010;12(4):R52. PMID:  20646288

